COSCIENS Biopharma, Inc. (CSCI.TO)
8.88
+0.13
(+1.49%)
CAD |
TSX |
Oct 05, 15:59
COSCIENS Biopharma Gross Profit Margin (Quarterly) : 55.27% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.27% |
| March 31, 2026 | 42.00% |
| December 31, 2025 | 34.49% |
| September 30, 2025 | 41.87% |
| June 30, 2025 | 31.15% |
| March 31, 2025 | 26.61% |
| December 31, 2024 | 61.68% |
| September 30, 2024 | 44.36% |
| June 30, 2024 | 35.04% |
| March 31, 2024 | 43.95% |
| December 31, 2023 | 12.12% |
| September 30, 2023 | 37.45% |
| June 30, 2023 | 57.26% |
| March 31, 2023 | 97.32% |
| December 31, 2022 | 96.70% |
| September 30, 2022 | 97.47% |
| June 30, 2022 | |
| March 31, 2022 | 92.42% |
| December 31, 2021 | 93.93% |
| September 30, 2021 | 93.91% |
| June 30, 2021 | 96.97% |
| March 31, 2021 | 96.10% |
| December 31, 2020 | 38.55% |
| September 30, 2020 | 41.38% |
| June 30, 2020 | 25.05% |
| Date | Value |
|---|---|
| March 31, 2020 | 11.10% |
| December 31, 2019 | -1.95K% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 11.86% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | -2.44% |
| September 30, 2018 | 23.68% |
| June 30, 2018 | -29.78% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 39.21% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Spectral Medical, Inc. | -186.3% |
| Resverlogix Corp. | -- |
| Theratechnologies, Inc. | -- |
| Restart Life Sciences Corp. | -213.3% |
| Covalon Technologies Ltd. | 65.12% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.16% |
| Return on Assets | -19.84% |
| Return on Invested Capital | -38.43% |
| Profit Margin (Quarterly) | -6.43% |
| Operating Margin (Quarterly) | 13.43% |
| Return on Net Operating Assets | -30.13% |